Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001703057-23-000027

Chief Executive Officer acquired 56,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hansen Carl L. G. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-24 Exercise or conversion : show line 1 in the form +56,125 $2.70 $151,538 617,375 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-24 Exercise or conversion : show line 2 in the form Share option (right to buy) −56,125 6,445,316 D
Loading xslF345X05/wk-form4_1692986225.xml…